Whalesbook
### Banking Sector Shows Divergent Fortunes
Indian banks presented a mixed earnings picture on January 27, 2026. Axis Bank posted a 3% year-on-year profit increase for its third quarter, reaching ₹6,489.6 crore, supported by a 5% rise in net interest income and a dip in gross non-performing assets to 1.40% [cite: News1]. Kotak Mahindra Bank reported a 4.3% profit rise to ₹3,446.1 crore, with net interest income up 5.1%, while also announcing plans to raise up to ₹15,000 crore via non-convertible debentures in FY27 [cite: News1]. In contrast, IndusInd Bank's profit plummeted 88.5% to ₹161.2 crore, primarily due to a significant 19.8% jump in provisions and contingencies. DCB Bank bucked the trend with a robust 22% profit surge to ₹184.7 crore [cite: News1]. The broader banking sector, particularly private players, has shown a shifting landscape with some entities consolidating leadership while others navigate profitability pressures.
### Industrials and Infrastructure Lead Gains
The industrial and infrastructure segments displayed strong momentum. UltraTech Cement emerged as a notable performer, announcing a 26.8% consolidated profit jump to ₹1,729.4 crore on a 22.8% revenue increase to ₹21,829.7 crore [cite: News1]. JSW Energy reported a dramatic 150.2% profit surge to ₹419.9 crore, fueled by a 67.4% revenue jump to ₹4,081.8 crore [cite: News1, 7]. Bharat Petroleum Corporation recorded an 88.9% profit spike to ₹7,188.4 crore, with revenue rising 5.2% to ₹1.19 lakh crore [cite: News1, 17]. Hindustan Copper's selection as the preferred bidder for a mining lease in Madhya Pradesh marks a significant development for the state-owned miner [cite: News1, 8]. Jayaswal Neco Industries entered into a Memorandum of Understanding with the Government of Maharashtra for a substantial ₹12,262 crore steel plant project [cite: News1]. The M&A outlook for 2026 remains strong, with energy and infrastructure sectors being critical components of deal rationales.
### Pharma and Technology Navigate Regulatory and Strategic Moves
In the pharmaceutical and technology sectors, companies focused on strategic acquisitions and regulatory compliance. HCL Technologies is set to acquire Singapore-based wealth consulting firm Finergic Solutions for S$19 million, an acquisition expected to conclude by April 30, 2026 [cite: News1]. Torrent Pharmaceuticals increased its stake in JB Chemicals to 48.75% by acquiring an additional 2.36% stake. Crucially, its Dahej facility received zero observations following a US FDA inspection, a positive signal for its operations [cite: News1]. Conversely, Zydus Lifesciences' Ankleshwar unit concluded a US FDA inspection with three observations, although none were related to data integrity [cite: News1]. The Indian pharmaceutical industry is projected for 9-11% growth in FY2026, with a focus on quality and regulatory alignment becoming paramount.
### Other Significant Corporate Developments
Waaree Renewable Technologies plans to acquire a significant 55% stake in Associated Power Structures for ₹1,225 crore, bolstering its presence in the power transmission and distribution business [cite: News1]. PVR Inox further streamlined its portfolio by monetising its investment in the 4700BC brand subsidiary, Zea Maize Private Limited, for ₹226.8 crore [cite: News1, 42]. Urban Company reported a loss of ₹21.3 crore in its third quarter, a shift from prior year profitability, despite revenue growth [cite: News1]. Paradeep Phosphates disclosed receiving a seizure memo from the Customs Department for 25,000 metric tonnes of technical-grade urea valued at ₹103.30 crore, though the company stated no material impact on financials is expected [cite: News1, 9, 15]. The nation's banking services experienced potential disruption from a one-day strike called by the United Forum of Bank Unions on January 27th [cite: News1].